Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

WRBY vs EYE vs NVST vs HSIC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
WRBY
Warby Parker Inc.

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$3.34B
5Y Perf.-48.7%
EYE
National Vision Holdings, Inc.

Specialty Retail

Consumer CyclicalNASDAQ • US
Market Cap$1.81B
5Y Perf.-59.8%
NVST
Envista Holdings Corp

Medical - Equipment & Services

HealthcareNYSE • US
Market Cap$4.04B
5Y Perf.-41.9%
HSIC
Henry Schein, Inc.

Medical - Distribution

HealthcareNASDAQ • US
Market Cap$8.09B
5Y Perf.-7.4%

WRBY vs EYE vs NVST vs HSIC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
WRBY logoWRBY
EYE logoEYE
NVST logoNVST
HSIC logoHSIC
IndustryMedical - Instruments & SuppliesSpecialty RetailMedical - Equipment & ServicesMedical - Distribution
Market Cap$3.34B$1.81B$4.04B$8.09B
Revenue (TTM)$891M$1.99B$2.81B$13.18B
Net Income (TTM)$1M$30M$68M$398M
Gross Margin53.4%56.5%55.1%29.1%
Operating Margin-0.7%3.0%9.0%5.8%
Forward P/E56.7x32.6x17.2x13.3x
Total Debt$233M$695M$1.71B$3.69B
Cash & Equiv.$286M$39M$1.21B$156M

WRBY vs EYE vs NVST vs HSICLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

WRBY
EYE
NVST
HSIC
StockSep 21May 26Return
Warby Parker Inc. (WRBY)10051.3-48.7%
National Vision Hol… (EYE)10040.2-59.8%
Envista Holdings Co… (NVST)10058.1-41.9%
Henry Schein, Inc. (HSIC)10092.6-7.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: WRBY vs EYE vs NVST vs HSIC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HSIC leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Warby Parker Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
WRBY
Warby Parker Inc.
The Growth Play

WRBY is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 13.0%, EPS growth 107.7%, 3Y rev CAGR 13.4%
  • 13.0% revenue growth vs HSIC's 4.0%
  • +68.3% vs HSIC's +5.9%
Best for: growth exposure
EYE
National Vision Holdings, Inc.
The Income Pick

EYE is the clearest fit if your priority is income & stability.

  • Dividend streak 2 yrs, beta 1.62
Best for: income & stability
NVST
Envista Holdings Corp
The Defensive Pick

NVST is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 1.65, Low D/E 55.0%, current ratio 2.38x
Best for: sleep-well-at-night
HSIC
Henry Schein, Inc.
The Long-Run Compounder

HSIC carries the broadest edge in this set and is the clearest fit for long-term compounding and valuation efficiency.

  • 5.3% 10Y total return vs NVST's -13.1%
  • PEG 4.21 vs NVST's 11.53
  • Beta 0.73, current ratio 1.38x
  • Lower P/E (13.3x vs 17.2x), PEG 4.21 vs 11.53
Best for: long-term compounding and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthWRBY logoWRBY13.0% revenue growth vs HSIC's 4.0%
ValueHSIC logoHSICLower P/E (13.3x vs 17.2x), PEG 4.21 vs 11.53
Quality / MarginsHSIC logoHSIC3.0% margin vs WRBY's 0.2%
Stability / SafetyHSIC logoHSICBeta 0.73 vs WRBY's 2.22
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)WRBY logoWRBY+68.3% vs HSIC's +5.9%
Efficiency (ROA)HSIC logoHSIC3.6% ROA vs WRBY's 0.2%, ROIC 7.1% vs -1.3%

WRBY vs EYE vs NVST vs HSIC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

WRBYWarby Parker Inc.
FY 2025
Eyewear Products
92.8%$719M
Services And Other
7.2%$56M
EYENational Vision Holdings, Inc.
FY 2025
Product Sales
44.7%$1.6B
Eyeglasses And Sunglasses
35.3%$1.3B
Services And Plans
10.7%$383M
Contact Lenses
9.0%$324M
Accessories And Other
0.3%$11M
NVSTEnvista Holdings Corp
FY 2024
Specialty Products and Technologies
64.4%$1.6B
Equipment and Consumables
35.6%$894M
HSICHenry Schein, Inc.
FY 2018
Healthcare Distribution
96.1%$12.7B
Technology
3.9%$509M

WRBY vs EYE vs NVST vs HSIC — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHSICLAGGINGNVST

Income & Cash Flow (Last 12 Months)

NVST leads this category, winning 3 of 6 comparable metrics.

HSIC is the larger business by revenue, generating $13.2B annually — 14.8x WRBY's $891M. Profitability is closely matched — net margins range from 3.0% (HSIC) to 0.2% (WRBY). On growth, EYE holds the edge at +15.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricWRBY logoWRBYWarby Parker Inc.EYE logoEYENational Vision H…NVST logoNVSTEnvista Holdings …HSIC logoHSICHenry Schein, Inc.
RevenueTrailing 12 months$891M$2.0B$2.8B$13.2B
EBITDAEarnings before interest/tax$32M$153M$342M$1.1B
Net IncomeAfter-tax profit$1M$30M$68M$398M
Free Cash FlowCash after capex$39M$73M$220M$561M
Gross MarginGross profit ÷ Revenue+53.4%+56.5%+55.1%+29.1%
Operating MarginEBIT ÷ Revenue-0.7%+3.0%+9.0%+5.8%
Net MarginNet income ÷ Revenue+0.2%+1.5%+2.4%+3.0%
FCF MarginFCF ÷ Revenue+4.4%+3.7%+7.8%+4.3%
Rev. Growth (YoY)Latest quarter vs prior year+8.3%+15.1%+14.4%+7.7%
EPS Growth (YoY)Latest quarter vs prior year+7.5%+111.3%+130.0%+14.9%
NVST leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

HSIC leads this category, winning 6 of 7 comparable metrics.

At 21.6x trailing earnings, HSIC trades at a 99% valuation discount to WRBY's 2076.3x P/E. Adjusting for growth (PEG ratio), HSIC offers better value at 6.84x vs NVST's 58.08x — a lower PEG means you pay less per unit of expected earnings growth.

MetricWRBY logoWRBYWarby Parker Inc.EYE logoEYENational Vision H…NVST logoNVSTEnvista Holdings …HSIC logoHSICHenry Schein, Inc.
Market CapShares × price$3.3B$1.8B$4.0B$8.1B
Enterprise ValueMkt cap + debt − cash$3.3B$2.5B$4.5B$11.6B
Trailing P/EPrice ÷ TTM EPS2076.34x61.70x86.73x21.56x
Forward P/EPrice ÷ next-FY EPS est.56.75x32.60x17.21x13.26x
PEG RatioP/E ÷ EPS growth rate58.08x6.84x
EV / EBITDAEnterprise value multiple73.08x16.20x13.28x10.87x
Price / SalesMarket cap ÷ Revenue3.83x0.91x1.49x0.61x
Price / BookPrice ÷ Book value/share9.25x2.12x1.32x1.79x
Price / FCFMarket cap ÷ FCF76.32x24.68x17.54x14.12x
HSIC leads this category, winning 6 of 7 comparable metrics.

Profitability & Efficiency

HSIC leads this category, winning 4 of 9 comparable metrics.

HSIC delivers a 8.2% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $0 for WRBY. NVST carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to EYE's 0.80x. On the Piotroski fundamental quality scale (0–9), EYE scores 7/9 vs HSIC's 4/9, reflecting strong financial health.

MetricWRBY logoWRBYWarby Parker Inc.EYE logoEYENational Vision H…NVST logoNVSTEnvista Holdings …HSIC logoHSICHenry Schein, Inc.
ROE (TTM)Return on equity+0.4%+3.5%+2.2%+8.2%
ROA (TTM)Return on assets+0.2%+1.5%+1.2%+3.6%
ROICReturn on invested capital-1.3%+3.0%+4.8%+7.1%
ROCEReturn on capital employed-1.0%+3.8%+4.9%+9.8%
Piotroski ScoreFundamental quality 0–96774
Debt / EquityFinancial leverage0.63x0.80x0.55x0.77x
Net DebtTotal debt minus cash-$53M$656M$496M$3.5B
Cash & Equiv.Liquid assets$286M$39M$1.2B$156M
Total DebtShort + long-term debt$233M$695M$1.7B$3.7B
Interest CoverageEBIT ÷ Interest expense3.54x12.76x4.59x
HSIC leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

WRBY leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in HSIC five years ago would be worth $8,746 today (with dividends reinvested), compared to $4,462 for EYE. Over the past 12 months, WRBY leads with a +68.3% total return vs HSIC's +5.9%. The 3-year compound annual growth rate (CAGR) favors WRBY at 31.0% vs NVST's -11.3% — a key indicator of consistent wealth creation.

MetricWRBY logoWRBYWarby Parker Inc.EYE logoEYENational Vision H…NVST logoNVSTEnvista Holdings …HSIC logoHSICHenry Schein, Inc.
YTD ReturnYear-to-date+20.2%-12.0%+12.0%-8.2%
1-Year ReturnPast 12 months+68.3%+46.3%+44.2%+5.9%
3-Year ReturnCumulative with dividends+125.0%+2.2%-30.3%-11.7%
5-Year ReturnCumulative with dividends-50.1%-55.4%-46.6%-12.5%
10-Year ReturnCumulative with dividends-50.1%-18.0%-13.1%+5.3%
CAGR (3Y)Annualised 3-year return+31.0%+0.7%-11.3%-4.0%
WRBY leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — WRBY and HSIC each lead in 1 of 2 comparable metrics.

HSIC is the less volatile stock with a 0.73 beta — it tends to amplify market swings less than WRBY's 2.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WRBY currently trades 87.7% from its 52-week high vs EYE's 76.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricWRBY logoWRBYWarby Parker Inc.EYE logoEYENational Vision H…NVST logoNVSTEnvista Holdings …HSIC logoHSICHenry Schein, Inc.
Beta (5Y)Sensitivity to S&P 5002.22x1.62x1.65x0.73x
52-Week HighHighest price in past year$31.00$30.02$30.42$89.29
52-Week LowLowest price in past year$14.96$14.38$16.33$61.95
% of 52W HighCurrent price vs 52-week peak+87.7%+76.0%+79.8%+79.0%
RSI (14)Momentum oscillator 0–10046.640.855.139.1
Avg Volume (50D)Average daily shares traded2.8M1.4M2.4M1.2M
Evenly matched — WRBY and HSIC each lead in 1 of 2 comparable metrics.

Analyst Outlook

EYE leads this category, winning 1 of 1 comparable metric.

Analyst consensus: WRBY as "Buy", EYE as "Buy", NVST as "Hold", HSIC as "Hold". Consensus price targets imply 54.2% upside for EYE (target: $35) vs 7.8% for WRBY (target: $29).

MetricWRBY logoWRBYWarby Parker Inc.EYE logoEYENational Vision H…NVST logoNVSTEnvista Holdings …HSIC logoHSICHenry Schein, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyHoldHold
Price TargetConsensus 12-month target$29.33$35.20$27.00$86.43
# AnalystsCovering analysts15141932
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises21
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.2%+4.1%+10.5%
EYE leads this category, winning 1 of 1 comparable metric.
Key Takeaway

HSIC leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). NVST leads in 1 (Income & Cash Flow). 1 tied.

Best OverallHenry Schein, Inc. (HSIC)Leads 2 of 6 categories
Loading custom metrics...

WRBY vs EYE vs NVST vs HSIC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is WRBY or EYE or NVST or HSIC a better buy right now?

For growth investors, Warby Parker Inc.

(WRBY) is the stronger pick with 13. 0% revenue growth year-over-year, versus 4. 0% for Henry Schein, Inc. (HSIC). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 6x trailing P/E (13. 3x forward), making it the more compelling value choice. Analysts rate Warby Parker Inc. (WRBY) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — WRBY or EYE or NVST or HSIC?

On trailing P/E, Henry Schein, Inc.

(HSIC) is the cheapest at 21. 6x versus Warby Parker Inc. at 2076. 3x. On forward P/E, Henry Schein, Inc. is actually cheaper at 13. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Henry Schein, Inc. wins at 4. 21x versus Envista Holdings Corp's 11. 53x.

03

Which is the better long-term investment — WRBY or EYE or NVST or HSIC?

Over the past 5 years, Henry Schein, Inc.

(HSIC) delivered a total return of -12. 5%, compared to -55. 4% for National Vision Holdings, Inc. (EYE). Over 10 years, the gap is even starker: HSIC returned +5. 3% versus WRBY's -50. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — WRBY or EYE or NVST or HSIC?

By beta (market sensitivity over 5 years), Henry Schein, Inc.

(HSIC) is the lower-risk stock at 0. 73β versus Warby Parker Inc. 's 2. 22β — meaning WRBY is approximately 203% more volatile than HSIC relative to the S&P 500. On balance sheet safety, Envista Holdings Corp (NVST) carries a lower debt/equity ratio of 55% versus 80% for National Vision Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — WRBY or EYE or NVST or HSIC?

By revenue growth (latest reported year), Warby Parker Inc.

(WRBY) is pulling ahead at 13. 0% versus 4. 0% for Henry Schein, Inc. (HSIC). On earnings-per-share growth, the picture is similar: National Vision Holdings, Inc. grew EPS 202. 8% year-over-year, compared to 7. 2% for Henry Schein, Inc.. Over a 3-year CAGR, WRBY leads at 13. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — WRBY or EYE or NVST or HSIC?

Henry Schein, Inc.

(HSIC) is the more profitable company, earning 3. 0% net margin versus 0. 2% for Warby Parker Inc. — meaning it keeps 3. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVST leads at 8. 3% versus -0. 6% for WRBY. At the gross margin level — before operating expenses — NVST leads at 55. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is WRBY or EYE or NVST or HSIC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Henry Schein, Inc. (HSIC) is the more undervalued stock at a PEG of 4. 21x versus Envista Holdings Corp's 11. 53x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Henry Schein, Inc. (HSIC) trades at 13. 3x forward P/E versus 56. 7x for Warby Parker Inc. — 43. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EYE: 54. 2% to $35. 20.

08

Which pays a better dividend — WRBY or EYE or NVST or HSIC?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is WRBY or EYE or NVST or HSIC better for a retirement portfolio?

For long-horizon retirement investors, Henry Schein, Inc.

(HSIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73)). Warby Parker Inc. (WRBY) carries a higher beta of 2. 22 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HSIC: +5. 3%, WRBY: -50. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between WRBY and EYE and NVST and HSIC?

These companies operate in different sectors (WRBY (Healthcare) and EYE (Consumer Cyclical) and NVST (Healthcare) and HSIC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

WRBY

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 32%
Run This Screen
Stocks Like

EYE

High-Growth Disruptor

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 33%
Run This Screen
Stocks Like

NVST

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 33%
Run This Screen
Stocks Like

HSIC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 17%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform WRBY and EYE and NVST and HSIC on the metrics below

Revenue Growth>
%
(WRBY: 8.3% · EYE: 15.1%)
P/E Ratio<
x
(WRBY: 2076.3x · EYE: 61.7x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.